John Hamill - Feb 27, 2023 Form 4 Insider Report for Aprea Therapeutics, Inc. (APRE)

Role
SrVP/CFO/Prin Fin & Acct Ofcr
Signature
/s/ John P. Hamill
Stock symbol
APRE
Transactions as of
Feb 27, 2023
Transactions value $
$5,250
Form type
4
Date filed
2/27/2023, 05:37 PM
Previous filing
Jan 30, 2023
Next filing
Mar 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APRE Common Stock Award $5.25K +1K +7.41% $5.25 14.5K Feb 27, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Effective February 13, 2023, the Issuer completed a 1-for-20 reverse stock split (the "Reverse Stock Split") of its outstanding Common Stock. The number of securities reported on this Form 4 has been adjusted to reflect the Reverse Stock Split.